The end of the year is an opportunity to take a step back.
At Sagitta Pharma, 2025 was an intense year, marked by sustained activity and the continuous mobilization of teams to tackle exciting challenges.
In our Sagitta Pharma 2025 Retrospective video, we look back at the key milestones of the past year.
This visual format highlights the key events that shaped 2025:
A constantly growing community of pharmacies
2025 was a very dynamic year: Sagitta Pharma continues to attract a growing number of pharmacies to its model.
This development reflects the relevance of our positioning and the trust placed in us by pharmacists, in a context where the reliability of partners is a key issue.
Sustained activity, reflecting our operational performance
2025 also saw an increase in the volume of logistics and commercial activity.
These results are based on improved organization, close coordination between teams, and the ability to maintain a level of service consistent with Good Distribution Practices.
Every order processed reflects the high standards that structure Sagitta Pharma's daily operations.
A wide and constantly evolving product range
2025 also saw the expansion of our product range, with numerous items added to meet the needs of pharmacies.
We highlight:
- the diversity of the products listed,
- the difference between our two activities: Purchasing center and Wholesaler-distributor,
- as well as the most representative products of the year.
This development is part of a process of continuous adaptation to the field, in order to better meet the expectations of pharmacies and patients.
Quality partners
The year was also marked by close collaboration with our partner laboratories, key players in the availability, quality, and competitiveness of our offering.
PharmaSmile: our exclusive brand in development
The Sagitta Pharma 2025 Retrospective video also highlights the evolution of PharmaSmile, the exclusive brand developed by Sagitta Pharma.
This video also highlights the progress of PharmaSmile, Sagitta Pharma's exclusive brand, launched at the end of 2024, which has quickly and seamlessly integrated into our customers' pharmacy shelves, complementing their traditional brands.
These results confirm the relevance of its positioning within the Sagitta Pharma offering.
A year of continuity
The Sagitta Pharma 2025 retrospective marks a milestone.
The projects launched in 2025 are continuing, and preparations for 2026 are underway, in line with the company's model and values.
